TD Cowen lowered the firm’s price target on Humana (HUM) to $173 from $260 and keeps a Hold rating on the shares. The firm updated its model following guidance of earnings of at least $9/share which includes roughly 25% MA growth, with a slightly below breakeven margin expectation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana price target lowered to $180 from $231 at Deutsche Bank
- Balanced Risk-Reward Amid Growth Ambitions and Margin Rebuild Supports Humana Hold Rating
- Midday Fly By: Cisco reports Q2 beat, Trump orders Pentagon to buy coal
- Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls
- Humana price target lowered to $195 from $285 at UBS